Fundz

4TEEN4 raised €55M in a Series C extension funding round to enhance PROCARD 2a study in Europe and expand into the U.S.

PRIVATENov 13, 2025

Amount Raised

€55 Million

Round Type

Series C

HennigsdorfBiotechnologyHealth Care

Description

4TEEN4, a Berlin-based pharmaceutical company, secured €55M in Series C extension funding. The financing will broaden its PROCARD 2a study footprint in Europe and support U.S. expansion. This funding aims to increase patient access to procizumab and enhance operational readiness for a pivotal trial.

Quick answer

4TEEN4 raised €55 Million in a Series C round, dated November 13, 2025. 4TEEN4 is based in Hennigsdorf, Brandenburg, Germany.

How much did 4TEEN4 raise?
4TEEN4 raised €55 Million in a Series C round on November 13, 2025.
What does 4TEEN4 do?
4TEEN4 is developing proprietary monoclonal antibody, Procizumab, that designed to neutralize circulating dipeptidyl peptidase 3 (cDPP3), a cardiac depression factor and key pathological driver in shock, which is a..
Where is 4TEEN4 based and how big is it?
4TEEN4 is based in Hennigsdorf, Brandenburg, Germany.
Who are the decision-makers at 4TEEN4?
Fundz holds 3 contacts at 4TEEN4, including the Chief Scientific Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as 4TEEN4 that raised within 45 days of this round, from Fundz verified event records.

  • CASI Pharmaceuticals raised $5M on December 27, 2025.
  • Initiate raised an undisclosed amount (Private Equity) on December 23, 2025.
  • FONAR raised $41M on December 23, 2025.
  • Vyriad raised $25M (Series B) on December 23, 2025.
  • Kashiv BioSciences raised $72M (Debt Financing) on December 23, 2025.
  • FONAR raised $10M on December 23, 2025.

Who to call at 4TEEN4, and when

A new round usually means 4TEEN4 is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day 4TEEN4 raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 4TEEN4, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 4TEEN4. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

4TEEN4

Location

Hennigsdorf, Brandenburg, Germany

About

4TEEN4 is developing proprietary monoclonal antibody, Procizumab, that designed to neutralize circulating dipeptidyl peptidase 3 (cDPP3), a cardiac depression factor and key pathological driver in shock, which is a life-threatening condition characterized by acute circulatory failure resulting from end-stage disease or sudden critical events. It often leads to multi-organ failure and is associated with mortality rates exceeding 50%. The ongoing multicenter, randomized, double-blind, placebo-controlled Phase 2a trial is evaluating the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of procizumab, in patients with cardiogenic shock and elevated cDPP3 levels.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment 4TEEN4 raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsKarine B., Chief Scientific Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for 4TEEN4's next move

See what Strategic adds

4TEEN4 raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.